Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Airmid Inc.

Headquarters: Redwood City, CA, United States of America
Website: N/A
Year Founded: 2006
Status: Archived

Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.

BioCentury | May 18, 2015
Clinical News

Dalazatide: Phase Ib data

BioCentury | May 11, 2015
Product Development

Check your effectors

Phase Ib data suggest Kineta's Kv1.3 blocker may quell autoimmune flares
BioCentury | Apr 6, 2015
Clinical News

Airmid, Kineta preclinical data

BioCentury | Feb 2, 2015
Clinical News

ShK-186: Phase Ib complete enrollment

BioCentury | Oct 20, 2014
Clinical News

ShK-186: Phase Ib started

BioCentury | Apr 21, 2014
Company News

Kineta, RLB Holdings deal

BioCentury | Apr 17, 2014
Distillery Therapeutics

Indication: Inflammation

BioCentury | Dec 9, 2013
Clinical News

ShK-186: Phase Ib started

BioCentury | Jun 6, 2013
Targets & Mechanisms

Watching obesity on a new channel

Items per page:
1 - 10 of 19